Annual EBITDA:
-$436.83M+$128.64M(+22.75%)Summary
- As of today, BBIO annual EBITDA is -$436.83 million, with the most recent change of +$128.64 million (+22.75%) on December 31, 2024.
- During the last 3 years, BBIO annual EBITDA has risen by +$97.00 million (+18.17%).
- BBIO annual EBITDA is now -896.89% below its all-time high of -$43.82 million, reached on December 31, 2017.
Performance
BBIO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$142.70M-$16.52M(-13.09%)Summary
- As of today, BBIO quarterly EBITDA is -$142.70 million, with the most recent change of -$16.52 million (-13.09%) on June 30, 2025.
- Over the past year, BBIO quarterly EBITDA has dropped by -$91.67 million (-179.63%).
- BBIO quarterly EBITDA is now -839.32% below its all-time high of $19.30 million, reached on June 30, 2022.
Performance
BBIO Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$643.59M-$91.67M(-16.61%)Summary
- As of today, BBIO TTM EBITDA is -$643.59 million, with the most recent change of -$91.67 million (-16.61%) on June 30, 2025.
- Over the past year, BBIO TTM EBITDA has dropped by -$275.45 million (-74.82%).
- BBIO TTM EBITDA is now -1418.01% below its all-time high of -$42.40 million, reached on March 31, 2018.
Performance
BBIO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
BBIO EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +22.8% | -179.6% | -74.8% |
| 3Y3 Years | +18.2% | -839.3% | -44.6% |
| 5Y5 Years | -56.6% | -15.1% | -51.9% |
BBIO EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -9.9% | +22.8% | -1186.4% | +39.3% | -89.7% | at low |
| 5Y | 5-Year | -56.6% | +22.8% | -839.3% | +39.3% | -89.7% | at low |
| All-Time | All-Time | -896.9% | +22.8% | -839.3% | +39.3% | -1418.0% | at low |
BBIO EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$142.70M(-13.1%) | -$643.59M(-16.6%) |
| Mar 2025 | - | -$126.18M(+46.3%) | -$551.92M(-26.3%) |
| Dec 2024 | -$436.83M(+22.7%) | -$235.05M(-68.3%) | -$436.83M(-24.7%) |
| Sep 2024 | - | -$139.66M(-173.7%) | -$350.26M(+4.9%) |
| Jun 2024 | - | -$51.03M(-360.0%) | -$368.14M(+19.2%) |
| Mar 2024 | - | -$11.09M(+92.5%) | -$455.58M(+19.4%) |
| Dec 2023 | -$565.47M(-42.3%) | -$148.47M(+5.8%) | -$565.47M(-5.5%) |
| Sep 2023 | - | -$157.54M(-13.8%) | -$535.91M(-7.8%) |
| Jun 2023 | - | -$138.47M(-14.5%) | -$497.09M(-46.5%) |
| Mar 2023 | - | -$120.98M(-1.7%) | -$339.32M(+14.6%) |
| Dec 2022 | -$397.44M(+25.5%) | -$118.92M(-0.2%) | -$397.44M(+4.0%) |
| Sep 2022 | - | -$118.72M(-715.1%) | -$414.14M(+7.0%) |
| Jun 2022 | - | $19.30M(+110.8%) | -$445.11M(+19.4%) |
| Mar 2022 | - | -$179.10M(-32.1%) | -$552.16M(-3.4%) |
| Dec 2021 | -$533.83M | -$135.62M(+9.4%) | -$533.83M(-2.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$149.68M(-70.6%) | -$521.84M(-6.2%) |
| Jun 2021 | - | -$87.75M(+45.4%) | -$491.39M(+6.9%) |
| Mar 2021 | - | -$160.78M(-30.0%) | -$527.61M(-13.1%) |
| Dec 2020 | -$467.38M(-67.5%) | -$123.63M(-3.7%) | -$466.36M(-10.0%) |
| Sep 2020 | - | -$119.24M(+3.8%) | -$423.85M(-16.7%) |
| Jun 2020 | - | -$123.97M(-24.5%) | -$363.16M(-16.6%) |
| Mar 2020 | - | -$99.53M(-22.7%) | -$311.59M(-11.4%) |
| Dec 2019 | -$278.96M(-67.1%) | -$81.11M(-38.5%) | -$279.82M(-13.4%) |
| Sep 2019 | - | -$58.55M(+19.1%) | -$246.77M(-7.7%) |
| Jun 2019 | - | -$72.39M(-6.8%) | -$229.06M(-19.2%) |
| Mar 2019 | - | -$67.77M(-41.0%) | -$192.13M(-15.2%) |
| Dec 2018 | -$166.90M(-280.9%) | -$48.06M(-17.7%) | -$166.76M(-40.5%) |
| Sep 2018 | - | -$40.84M(-15.2%) | -$118.70M(-52.5%) |
| Jun 2018 | - | -$35.45M(+16.4%) | -$77.85M(-83.6%) |
| Mar 2018 | - | -$42.40M | -$42.40M |
| Dec 2017 | -$43.82M | - | - |
FAQ
- What is BridgeBio Pharma, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for BridgeBio Pharma, Inc.?
- What is BridgeBio Pharma, Inc. annual EBITDA year-on-year change?
- What is BridgeBio Pharma, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for BridgeBio Pharma, Inc.?
- What is BridgeBio Pharma, Inc. quarterly EBITDA year-on-year change?
- What is BridgeBio Pharma, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for BridgeBio Pharma, Inc.?
- What is BridgeBio Pharma, Inc. TTM EBITDA year-on-year change?
What is BridgeBio Pharma, Inc. annual EBITDA?
The current annual EBITDA of BBIO is -$436.83M
What is the all-time high annual EBITDA for BridgeBio Pharma, Inc.?
BridgeBio Pharma, Inc. all-time high annual EBITDA is -$43.82M
What is BridgeBio Pharma, Inc. annual EBITDA year-on-year change?
Over the past year, BBIO annual EBITDA has changed by +$128.64M (+22.75%)
What is BridgeBio Pharma, Inc. quarterly EBITDA?
The current quarterly EBITDA of BBIO is -$142.70M
What is the all-time high quarterly EBITDA for BridgeBio Pharma, Inc.?
BridgeBio Pharma, Inc. all-time high quarterly EBITDA is $19.30M
What is BridgeBio Pharma, Inc. quarterly EBITDA year-on-year change?
Over the past year, BBIO quarterly EBITDA has changed by -$91.67M (-179.63%)
What is BridgeBio Pharma, Inc. TTM EBITDA?
The current TTM EBITDA of BBIO is -$643.59M
What is the all-time high TTM EBITDA for BridgeBio Pharma, Inc.?
BridgeBio Pharma, Inc. all-time high TTM EBITDA is -$42.40M
What is BridgeBio Pharma, Inc. TTM EBITDA year-on-year change?
Over the past year, BBIO TTM EBITDA has changed by -$275.45M (-74.82%)